Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas
Clinical trial NCT02158975 · COMPLETED
Trial details
- NCT number
- NCT02158975
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-10-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.